T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

August 1, 2026

Conditions

Prostate Cancer

Interventions

DRUG

Simvastatin 40mg

Simvastatin 40mg taken orally daily for 8 weeks

Trial Locations (2)

RECRUITING

Hollings Cancer Center at Medical University of South Carolina, Charleston

NOT_YET_RECRUITING

Emory University, Atlanta

All Listed Sponsors

lead

Medical University of South Carolina

OTHER